| abstract |
The present invention relates to an epitope specific for hepatitis B virus (HBV) and its use, and since the epitope provided in the present invention is a conserved site in which modification by mutation does not occur, a composition comprising an antibody against the epitope. Alternatively, the vaccine composition comprising the epitope is very useful for HBV treatment because it is unlikely to decrease the therapeutic effect due to mutation of HBV. |